Advertisement

Optimizing Management of Heart Failure by Using Echo and Natriuretic Peptides in the Outpatient Unit

  • Frank Lloyd DiniEmail author
  • Gani Bajraktari
  • Cornelia Zara
  • Nicola Mumoli
  • Gian Marco Rosa
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1067)

Abstract

Chronic heart failure (HF) is an important public health problem and is associated with high morbidity, high mortality, and considerable healthcare costs. More than 90% of hospitalizations due to worsening HF result from elevations of left ventricular (LV) filling pressures and fluid overload, which are often accompanied by the increased synthesis and secretion of natriuretic peptides (NPs). Furthermore, persistently abnormal LV filling pressures and a rise in NP circulating levels are well known indicators of poor prognosis. Frequent office visits with the resulting evaluation and management are most often needed. The growing pressure from hospital readmissions in HF patients is shifting the focus of interest from traditionally symptom-guided care to a more specific patient-centered follow-up care based on clinical findings, BNP and echo. Recent studies supported the value of serial NP measurements and Doppler echocardiographic biomarkers of elevated LV filling pressures as tools to scrutinize patients with impending clinically overt HF. Therefore, combination of echo and pulsed-wave blood-flow and tissue Doppler with NPs appears valuable in guiding ambulatory HF management, since they are potentially useful to distinguish stable patients from those at high risk of decompensation.

Keywords

Heart failure Natriuretic peptides Pulmonary capillary wedge pressure Echocardiography Ejection fraction Diastolic dysfunction Prognosis Hemodynamic profiles Cardiac output 

References

  1. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP, ADHERE Scientific Advisory Committee and Investigators (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149:209–216PubMedPubMedCentralCrossRefGoogle Scholar
  2. Ahmed A, Husain A, Love TE, Gambassi G, Dell’Italia LJ, Francis GS, Gheorghiade M, Allman RM, Meleth S, Bourge RC (2006) Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 27:1431–1439CrossRefPubMedPubMedCentralGoogle Scholar
  3. Appleton CP, Galloway JM, Gonzales MS, Gaballa M, Bansight MA (1993) Estimation of left ventricular filling pressures using two-dimensional and Doppler echocardiography in adult patients with cardiac disease. Additional value of analyzing left atrial size, left atrial ejection fraction and the difference in duration of pulmonary venous and mitral flow velocity at atrial contraction. J Am Coll Cardiol 22:1972–1982CrossRefPubMedGoogle Scholar
  4. Carluccio E, Dini FL, Biagioli P, Lauciello R, Simioniuc A, Zuchi C, Alunni G, Reboldi G, Marzilli M, Ambrosio G (2013) The ‘Echo Heart Failure Score’: an echocardiographic risk prediction score of mortality in systolic heart failure. Eur J Heart Fail 15:868–876CrossRefPubMedGoogle Scholar
  5. Coiro S, Rossignol P, Ambrosio G, Carluccio E, Alunni G, Murrone A, Tritto I, Zannad F, Girerd N (2015) Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure. Eur J Heart Fail 17:1172–1181CrossRefPubMedGoogle Scholar
  6. Damman K, Kjekshus J, Wikstrand J, Cleland JG, Komajada M, Wedel H, Waagstwin F, McMurray JJ (2016) Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction. Eur J Heart Fail 18:328–336CrossRefPubMedGoogle Scholar
  7. Desai AS, Stevenson LW (2012) Rehospitalization for heart failure: predict or prevent? Circulation 126:501–506CrossRefPubMedGoogle Scholar
  8. Dini FL, Dell’Anna R, Micheli A, Michelassi C, Rovai D (2000a) Impact of blunted pulmonary venous flow on the outcome of patients with left ventricular systolic dysfunction secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 85:1455–1460CrossRefPubMedGoogle Scholar
  9. Dini FL, Michelassi C, Micheli G, Rovai D (2000b) Prognostic value of pulmonary venous flow in left ventricular dysfunction: contribution of the difference in duration of pulmonary venous and mitral flow at atrial contraction. J Am Coll Cardiol 36:1295–1302CrossRefPubMedGoogle Scholar
  10. Dini FL, Cortigiani L, Baldini U, Boni A, Nuti R, Barsotti L, Micheli G (2002) Prognostic value of left atrial enlargement in patients with idiopathic dilated cardiomyopathy and ischemic cardiomyopathy. Am J Cardiol. 89:518–523CrossRefPubMedGoogle Scholar
  11. Dini FL, Ballo P, Badano L, Barbier P, Chella P, Conti U, De Tommasi SM, Galderisi M, Ghio S, Magagnini E, Pieroni A, Rossi A, Rusconi C, Temporelli PL (2010) Validation of an echo-Doppler decision model to predict left ventricular filling pressure in patients with heart failure independently of ejection fraction. Eur J Echocardiogr 11:703–710CrossRefPubMedGoogle Scholar
  12. Dini FL, Ghio S, Klersy C, Rossi A, Simioniuc A, Scelsi L, Genta FT, Cicoira M, Tavazzi L, Temporelli PL (2013) Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis. Int J Clin Pract 67:656–664CrossRefPubMedGoogle Scholar
  13. Dini FL, Carluccio E, Monteccucco F, Rosa GM, Fontanive P (2017) Combining echo and natiuretic peptides to guide heart failure care in the outpatient setting: a position paper. Eur J Clin Invest:e12846.  https://doi.org/10.1111/eci.12846CrossRefGoogle Scholar
  14. Douglas PS, Khandheria B, Stainback RF, Weissman NJ, Brindis RG, Patel MR, Alpert JS, Fitzgerald D, Heidenreich P, Martin ET, Messer JV, Miller AB, Picard MH, Raggi P, Reed KD, Rumsfeld JS, Steimle AE, Tonkovic R, Vijayaraghavan K, Yeon SB, Hendel RC, Peterson E, Wolk MJ, Allen JM (2007) ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR (2007) Appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance endorsed by the American College of Chest Physicians and the Society of Critical Care Medicine. J Am Coll Cardiol 50:187–204Google Scholar
  15. Eurlings LW, van Pol PE, Kok WE, van Wijk S, Lodewijks-van der Bolt C, Balk AH, Lok DJ, Crijns HJ, van Kraaij DJ, de Jonge N, Meeder JG, Prins M, Pinto YM (2010) Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?). J Am Coll Cardiol 56:2090–2100CrossRefPubMedGoogle Scholar
  16. Fonarow GC, Stevenson LW, Walden JA et al (1997) Impact of a comprehensive heart failure management program on hospital readmission and functional status in patients with advanced heart failure. J Am Coll Cardiol 30:725–732CrossRefPubMedGoogle Scholar
  17. Forrester JS, Diamond GA, Swan HJ (1977) Correlative classification of clinical and hemodynamic function after acute myocardial infarction. Am J Cardiol 39:137–145CrossRefPubMedGoogle Scholar
  18. Frassi F, Gargani L, Gligorova S, Ciampi Q, Mottola G, Picano E (2007) Clinical and echocardiographic determinants of ultrasound lung comets. Eur J Echocardiogr 8:474CrossRefPubMedGoogle Scholar
  19. From AM, Lam CSP, Pitta SR, Kumar PV, Balbissi KA, Booker JD, Singh IM, Sorajja P, Reeder GS, Borlaug BA (2011) Bedside assessment of cardiac hemodynamics: the impact of noninvasive testing and examiner experience. Am J Med 124:1051–1057CrossRefPubMedGoogle Scholar
  20. Gaggin HK, Mohammed AA, Bhardwa J, Rehman SH, Gregory SA, Weiner RB, Baggish AL, Moore SA, Semigran MJ, Januzzi JL Jr (2012) Heart failure outcomes and benefits of NT-proBNP guided management in the elderly: results from the prospective, randomized ProBNP Outpatient Tailored Chronic Heart Failure therapy (PROTECT) study. J Cardiac Fail 18:626–634CrossRefGoogle Scholar
  21. Gargani L, Pang PS, Frassi F, Miglioranza MH, Dini FL, Landi P, Picano E (2015) Persistent pulmonary congestion before discharge predicts rehospitalization in heart failure: a lung ultrasound study. Cardiovasc Ultrasound 13:40CrossRefPubMedPubMedCentralGoogle Scholar
  22. Gheorghiade M, Follath F, Ponikowski P, Barsuk JH, Blair JE, Cleland JG, Dickstein K, Drazner MH, Fonarow GC, Jaarsma T, Jondeau G, Sendon JL, Mebazaa A, Metra M, Nieminen M, Pang PS, Seferovic P, Stevenson LW, van Veldhuisen DJ, Zannad F, Anker SD, Rhodes A, McMurray JJ, Filippatos G, European Society of Cardiology, European Society of Intensive Care Medicine (2010) Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail 12:423–433CrossRefPubMedGoogle Scholar
  23. Giannuzzi P, Imparato A, Temporelli PL, de Vito F, Silva PL, Scapellato F, Giordano A (1994) Doppler-derived mitral deceleration time of early filling as a strong predictor of pulmonary capillary wedge pressure in postinfarction patients with left ventricular systolic dysfunction. J Am Coll Cardiol 23:1630–1637CrossRefPubMedGoogle Scholar
  24. Harjai KJ, Dinshaw HK, Nunez E, Shah M, Thompson H, Turgut T, Ventura HO (1999) The prognostic implications of outpatient diuretic dose in heart failure. Int J Cardiol 71:219–225CrossRefPubMedGoogle Scholar
  25. Heidenreich PA, Albert NM, Allen LA et al (2013) Forecasting the impact of heart failure in the United States: a policy statement of the American Heart Association. Circ Heart Fail 6:606–619CrossRefPubMedPubMedCentralGoogle Scholar
  26. Hobbs RE, Mills RM (2008) Endogenous B-type natriuretic peptide: a limb of regulatory response to acutely decompensated heart failure. Clin Cardiol 31:407–412CrossRefPubMedGoogle Scholar
  27. Januzzi JL Jr, Rehman SU, Mohammed AA, Bhardwaj A, Barajas L, Barajas J, Kim HN, Baggish AL, Weiner RB, Chen-Tournoux A, Marshall JE, Moore SA, Carlson WD, Lewis GD, Shin J, Sullivan D, Parks K, Wang TJ, Gregory SA, Uthamalingam S, Semigran MJ (2011) Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J Am Coll Cardiol 58:1881–1889CrossRefPubMedGoogle Scholar
  28. Jourdain P, Jondeau G, Funck F, Gueffet P, Le Helloco A, Donal E, Aupetit JF, Aumont MC, Galinier M, Eicher JC, Cohen-Solal A, Juilliere Y (2007) Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 49:1733–1739CrossRefPubMedGoogle Scholar
  29. Kelder JC, Cramer NJ, Wijngaarden J, van Tooren R, Mosterd A, Moos KGM, Lammers JW, Cowie MR, Grobbee DE, Hoes AW (2011) The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure. Circulation 124:2865–2873CrossRefPubMedGoogle Scholar
  30. Krumholtz HM, Chen YT, Wang Y et al (2000) Predictors of readmission among elederly survivors of admission with heart failure. Am Heart J 139:72–77CrossRefGoogle Scholar
  31. Lainchbury JG, Troughton RW, Strangman KM, Frampton CM, Pilbrow A, Yandle TG, Hamid AK, Nicholls MG, Richards AM (2010) N-Terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-assisted treatment to lessen serial cardiac readmissions and death) trial. J Am Coll Cardiol 55:53–60CrossRefGoogle Scholar
  32. Lester SJ, Tajik AJ, Nishimura RA, Oh JK, Khandheria BK, Seward JB (2008) Unlocking the mysteries of diastolic function: deciphering the Rosetta Stone 10 years later. J Am Coll Cardiol 51:679–689CrossRefPubMedGoogle Scholar
  33. Leye M, Brochet E, Lepage L, Cueff C, Boutron I, Detaint D, Hyafil F, Iung B, Vahanian A, Messika-Zeitoun D (2009) Size-adjusted left ventricular outflow tract diameter reference values: a safeguard for the evaluation of the severity of aortic stenosis. J Am Soc Echocardiogr 22:445–451CrossRefPubMedGoogle Scholar
  34. Maisel AS, Krishnaswamy P, Novak RM et al (2002) Rapid measurement of B-type natriuretic peptide in the emergerncy diagnosis of heart failure. N Engl J Med 347:161–167CrossRefPubMedGoogle Scholar
  35. Maisel A, Mueller C, Adams K Jr et al (2008) State of art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 10:824–839CrossRefPubMedGoogle Scholar
  36. McKie PM, Schirger JA, Benike SL, Harstad LK, Chen HH (2014) The effects of dose reduction of furosemide on glomerular filtration rate in stable systolic heart failure. JACC Heart Fail 2:675–677CrossRefPubMedPubMedCentralGoogle Scholar
  37. Miglioranza MH, Gargani L, Sant’Anna RT, Rover MM, Martins VM, Mantovani A et al (2013) Lung ultrasound for the evaluation of pulmonary congestion in outpatients: a comparison with clinical assessment, natriuretic peptides, and echocardiography. JACC Cardiovasc Imaging 6:1141–1151CrossRefPubMedGoogle Scholar
  38. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA (1997) Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30:1527–1533CrossRefPubMedGoogle Scholar
  39. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 17:1321–1360CrossRefPubMedGoogle Scholar
  40. Nishimura RA, Tajik AJ (1997) Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is clinician’s Rosetta stone. J Am Coll Cardiol 30:8–18CrossRefPubMedGoogle Scholar
  41. Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, Stevenson LW (2003) Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 41:1797–1804CrossRefPubMedGoogle Scholar
  42. Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP, TIME-CHF Investigators (2009) BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA 301:383–392CrossRefPubMedGoogle Scholar
  43. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors/Task Force Members (2016) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200CrossRefGoogle Scholar
  44. Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA (2002) Doppler quantification task force of the nomenclature and standards committee of the American society of echocardiography. Recommendations for quantification of doppler echocardiography: a report from the doppler quantification task force of the nomenclature and standards committee of the American society of echocardiography. J Am Soc Echocardiogr 15:167–184CrossRefPubMedGoogle Scholar
  45. Ross JS, Chen J, Lin Z et al (2010) Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail 3:97–103CrossRefPubMedGoogle Scholar
  46. Rossi A, Cicoira M, Zanolla L et al (2002) Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. J Am Coll Cardiol 40:1425CrossRefPubMedGoogle Scholar
  47. Scali MC, Simioniuc A, Dini FL, Marzilli M (2014) The potential value of integrated natriuretic peptide and echo-guided heart failure management. Cardiovasc Ultrasound 12:27CrossRefPubMedPubMedCentralGoogle Scholar
  48. Shah NB, Der E, Ruggerio C, Heidenreich PA, Massie BM (1998) Prevention of hospitalizations for heart failure with an interactive home monitoring program. Am Heart J 135:373–378CrossRefPubMedGoogle Scholar
  49. Shah MR, Califf RM, Nohria A, Bhapkar M, Bowers M, Mancini DM, Fiuzat M, Stevenson LW, Connor CM (2011) The STARBRITE Trial: a randomized, pilot study of B-type natriuretic peptide guided therapy in patients with advanced heart failure. J Cardiac Fail 17:613–621CrossRefGoogle Scholar
  50. Shiran A, Adawi S, Ganaeem M, Asmer E (2009) Accuracy and reproducibility of left ventricular outflow tract diameter measurement using transthoracic when compared with transesophageal echocardiography in systole and diastole. Eur J Echocardiogr 10:319–324CrossRefPubMedGoogle Scholar
  51. Simioniuc A, Carluccio E, Ghio S, Rossi A, Biagioli P, Reboldi G, Galeotti GG, Lu F, Zara C, Whalley G, Temporelli PG, Dini FL (2016) Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: an observational study of 1137 outpatients. Int J Cardiol 224:416–423CrossRefPubMedGoogle Scholar
  52. Spencer KT, Kimura BJ, Korcarz CE, Pellikka P, Rahko PS, Siegel RJ (2013) Focused cardiac ultrasound: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr 26:567–581CrossRefPubMedGoogle Scholar
  53. Stevenson LW, Tillisch JH, Hamilton M et al (1990) Importance of hemodynamic response to therapy in predicting survival with ejection fraction <20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 66:1348–1354CrossRefPubMedGoogle Scholar
  54. Stevenson LW (2006) Are hemodynamic goals viable in tailoring heart failure therapy? Hemodynamic goals are relevant. Circulation 113:1020–1027CrossRefPubMedGoogle Scholar
  55. Stevenson LW, Perloff JK (1989) The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261:884–888CrossRefPubMedGoogle Scholar
  56. Stienen S, Salah K, Eurlings LWM, Bettencourt P, Pimenta JM, Metra M, Bayes-Genis A, Verdiani V, Bettari L, Lazzarini V, Tijssen JP, Pinto YM, Kok WEM (2015) Challenging the two concepts in determining the appropriated pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels. Eur J Heart Fail 17:936–944CrossRefPubMedGoogle Scholar
  57. Tavazzi L, Senni M, Metra M, Gorini M, Cacciatore G, Chinaglia A, Di Lenarda A, Mortara A, Oliva F, Maggioni AP, IN-HF (Italian Network on Heart Failure) Outcome Investigators (2013) Multicenter prospective observational study on acute and chronic heart failure: one year follow-up results of IN-HF (Italian Network on Heart Failure) outcome registry. Circ Heart Fail 6:473–481CrossRefPubMedGoogle Scholar
  58. Temporelli PL, Corrà U, Imparato A, Bosimini E, Scapellato F, Giannuzzi P (1998) Reversible restrictive left ventricular diastolic filling with optimized oral therapy predicts more favorable prognosis in patients with chronic heart failure. J Am Coll Cardiol 31:1591–1597CrossRefPubMedGoogle Scholar
  59. The MeRGE Heart Failure Collaborators (2008) Independence of restrictive filling pattern and LV ejection fraction with mortality in heart failure: an individual patient meta-analysis. Eur J Heart Fail 10:786–792CrossRefGoogle Scholar
  60. Troughton R, Michael Felker G, Januzzi JL Jr (2014) Natriuretic peptide-guided heart failure management. Eur Heart J 35:16–24CrossRefPubMedGoogle Scholar
  61. Whalley GA, Doughty RN, Gamble GD, Wright SP, Walsh HJ, Muncaster SA, Sharpe N (2002) Pseudonormal mitral filling pattern predicts hospital re-admission in patients with congestive heart failure. J Am Coll Cardiol 39:1787–1795CrossRefPubMedGoogle Scholar
  62. Yamamoto K, Nishimura RA, Chaliki HP et al (1997) Determination of left ventricular filling pressure by Doppler echocardiography in patients with coronary artery disease: the critical role of left ventricular systolic function. J Am Coll Cardiol 30:1819–1826CrossRefPubMedGoogle Scholar
  63. Yin WH, Chen JW, Lin SJ (2012) Prognostic value of combining echocardiography and natriuretic peptide levels in patients with heart failure. Curr Heart Fail Rep 9:148–153CrossRefPubMedGoogle Scholar
  64. Zile MR, Claggett BL, Prescott MF, McMurray JJ, Packer M, Rouleau JL, Swedberg K, Desai AS, Gong J, Shi VC, Solomon SD (2016) Prognostic Implications of changes in N-Terminal pro-B-type natriuretic peptide in patients with heart failure. J Am Coll Cardiol 68:2425–2436CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Frank Lloyd Dini
    • 1
    • 6
    Email author
  • Gani Bajraktari
    • 2
    • 3
  • Cornelia Zara
    • 1
  • Nicola Mumoli
    • 4
  • Gian Marco Rosa
    • 5
  1. 1.Cardiovascular and Thoracic DepartmentUniversity of PisaPisaItaly
  2. 2.Department of Public Health and Clinical MedicineUmeå University and Heart CentreUmeåSweden
  3. 3.Clinic of CardiologyUniversity Clinical Centre of KosovaPrishtinaKosovo
  4. 4.Department of Internal MedicineLivorno HospitalLivornoItaly
  5. 5.Department of Internal Medicine and Medical SpecialitiesUniversity of GenoaGenoaItaly
  6. 6.Unità Operativa Malattie Cardiovascolari 1, Dipartimento Cardio, Toracico e VascolareAzienda Ospedaliera-Universitaria PisanaPisaItaly

Personalised recommendations